Guggenheim Capital’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $240K | Sell |
|
|||||
|
2025
Q2 | $211K | Sell |
|
|||||
|
2025
Q1 | $494K | Buy |
|
|||||
|
2024
Q4 | $732K | Sell |
|
|||||
|
2024
Q3 | $1.03M | Sell |
|
|||||
|
2024
Q2 | $902K | Buy |
|
|||||
|
2024
Q1 | $1.15M | Sell |
|
|||||
|
2023
Q4 | $887K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $711K | Sell |
|
|||||
|
2022
Q3 | $1.07M | Sell |
|
|||||
|
2022
Q2 | $1.42M | Buy |
|
|||||
|
2022
Q1 | $1.88M | Buy |
|
|||||
|
2021
Q4 | $2M | Buy |
|
|||||
|
2021
Q3 | $2.35M | Sell |
|
|||||
|
2021
Q2 | $2.55M | Buy |
|
|||||
|
2021
Q1 | $2.83M | Buy |
|
|||||
|
2020
Q4 | $3.22M | Sell |
|
|||||
|
2020
Q3 | $2.72M | Sell |
|
|||||
|
2020
Q2 | $3.09M | Buy |
|